Insmed prices follow-on after ALIS success

Insmed Inc. (NASDAQ:INSM) gained $1.25 to $30.61 on Thursday after raising $350 million through the sale of 12.3 million shares at $28.50 in a bumped-up follow-on underwritten by Goldman Sachs, Leerink, Evercore and Stifel. The price is a 6% premium to Insmed's close of $26.99 on Tuesday, when the company proposed after trading hours to raise $250 million...